全文获取类型
收费全文 | 801篇 |
免费 | 56篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 103篇 |
妇产科学 | 18篇 |
基础医学 | 100篇 |
口腔科学 | 17篇 |
临床医学 | 89篇 |
内科学 | 142篇 |
皮肤病学 | 21篇 |
神经病学 | 31篇 |
特种医学 | 126篇 |
外科学 | 67篇 |
综合类 | 14篇 |
预防医学 | 41篇 |
眼科学 | 2篇 |
药学 | 60篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 4篇 |
2021年 | 19篇 |
2020年 | 5篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2017年 | 7篇 |
2016年 | 15篇 |
2015年 | 14篇 |
2014年 | 19篇 |
2013年 | 29篇 |
2012年 | 22篇 |
2011年 | 21篇 |
2010年 | 33篇 |
2009年 | 42篇 |
2008年 | 21篇 |
2007年 | 37篇 |
2006年 | 30篇 |
2005年 | 23篇 |
2004年 | 21篇 |
2003年 | 10篇 |
2002年 | 12篇 |
2001年 | 19篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1998年 | 40篇 |
1997年 | 41篇 |
1996年 | 34篇 |
1995年 | 30篇 |
1994年 | 12篇 |
1993年 | 22篇 |
1992年 | 8篇 |
1991年 | 9篇 |
1990年 | 19篇 |
1989年 | 20篇 |
1988年 | 25篇 |
1987年 | 27篇 |
1986年 | 20篇 |
1985年 | 22篇 |
1984年 | 14篇 |
1983年 | 14篇 |
1982年 | 15篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 3篇 |
1978年 | 10篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1970年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有881条查询结果,搜索用时 15 毫秒
871.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA 《Blood》1995,86(3):1090-1071
B chronic lymphocytic leukemia (B-CLL) are clonal populations of mIgM+ or mIgM+/mIgD+ CD5+ B cells that appear to be arrested in the follicular mantle-zone B-cell stage. Functional analyses have shown two groups of B-CLL that can be distinguished based on their capacity to proliferate in response to B-cell antigen receptor complex (BCR) cross- linking. To investigate the molecular basis for this phenomenon, we have analyzed both architecture and functional properties of BCR complexes on these two groups of B-CLL. Both groups were found to express structurally similar BCR. However, protein tyrosine kinase (PTK) activity associated with and specific for BCR constituents was strongly diminished in nonresponsive B-CLL. Moreover, the PTK-dependent assembly of Shc/Grb2 complexes, which may couple the BCR to p21ras, was absent in these B-CLL. Finally, of all PTKs tested, the expression of PTK syk was found to be considerably lower in nonresponsive B-CLL. Thus, absence of mitogenic responses upon BCR cross-linking in particular B-CLL was found to be strictly correlated with diminished induction of BCR-associated PTK activity and lower levels of PTK syk. Because nonresponsive B-CLL closely resembles tolerant autoreactive B cells both functionally and biochemically, distinction between B-CLL with respect to functional properties in vitro may be determined by differences in antigen encounter in vivo. 相似文献
872.
Parker PM; Chao N; Nademanee A; O'Donnell MR; Schmidt GM; Snyder DS; Stein AS; Smith EP; Molina A; Stepan DE 《Blood》1995,86(9):3604-3609
Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixteen patients (20%) had a sustained response, 9 with a complete remission and 7 with a partial response. Twenty-nine patients (36%) had thalidomide discontinued because of side effects, which included sedation, constipation, neuritis, skin rash, and neutropenia. Side effects were reversible with drug discontinuation except for mild residual neuritis in one case. Rashes and neutropenia have not previously been reported as thalidomide side effects when used for CGVHD treatment. We conclude thalidomide is immunosuppressive and active in the treatment of CGVHD. A high incidence of reversible side effects limited dose intensity and reduced the number of patients who could benefit from treatment. 相似文献
873.
C Edwards PhD DA Blowers BSc DObstRCOG FFPM GM Pover MB ChB FFPM 《International journal of clinical practice》1997,51(6):394-398
This open, non-comparative, PMS study of fosinopril (StarilTM) involved 12,067 hypertensive patients assessed at baseline and after two and six months of treatment; 10,791 patients provided evaluable data with 5.2 months average treatment totalling 4667 patient-years. Adverse events were reported in 24% of patients, the most common being mild-to-moderate cough (6.05%). Events considered possibly related to fosinopril were reported in 15% of patients, the frequency being lower in younger patients, males and those receiving fosinopril monotherapy. Patient well-being improved during the study. At the end of the study, most patients were taking fosinopril 10 mg once daily. Mean reductions in systolic and diastolic blood pressures were -11.0% and -11.7%, respectively; 71.3% of patients were ‘responders’. No important differences were observed between subgroups. This study found fosinopril to be effective, well tolerated in a broad range of hypertensive patients, and with no previously unrecognised adverse events reported. 相似文献
874.
The effectiveness of elemental, nontoxic carbonyl iron in replacing iron lost at blood donation was examined. In a randomized double-blind design, 99 women, aged 18 to 40, were given placebo or low-dose carbonyl iron (100 mg orally) at bedtime for 56 days after phlebotomy. Compliance was equivalent for the two regimens. Mild side effects were slightly greater with carbonyl iron. At Day 56, estimated net iron absorption from therapy or diet, or both, was sufficient to replace iron in 85 percent of those receiving carbonyl iron but in only 29 percent of those taking placebo (p less than 0.001). The rates of deferral from repeat donation were 8 percent in the carbonyl iron group and 36 percent in the placebo group (p less than 0.01), and the positive predictive value of routine screening in identifying participants without iron deficiency was 83 versus 13 percent (p less than 0.01). It can be concluded that short-term carbonyl iron supplementation in female blood donors can replace the iron lost at phlebotomy, protect the women against iron deficiency, and enhance their ability to give blood. 相似文献
875.
Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot 总被引:3,自引:0,他引:3
JB Jackson ; MR Hanson ; GM Johnson ; TG Spahlinger ; HF Polesky ; RJ Bowman 《Transfusion》1995,35(2):98-102
BACKGROUND: At present, tens of thousands of United States blood donors who are at low risk for human immunodeficiency virus type 1 (HIV-1) infection are indefinitely deferred. These persons are repeatably reactive for HIV-1 antibody in enzyme immunoassay (EIA) and are indeterminate in Western blot. STUDY DESIGN AND METHODS: To determine the significance and persistence of anti-HIV-1 reactivity in plasma from volunteer blood donors with HIV-1-indeterminate Western blots, 66 donors were retested for HIV-1 antibody by the same manufacturers' EIA and Western blot 5 to 7 years after the initial Western blot. In addition, donors' peripheral blood mononuclear cells were tested by polymerase chain reaction (PCR) for HIV-1 DNA gag sequences. RESULTS: Thirty-five (53%) of 66 donors were still repeatedly reactive for HIV-1 on EIA and indeterminate on Western blot, 23 (35%) were negative on EIA and indeterminate on Western blot, 7 (11%) were negative in EIA and Western blot, and 1 (2%) was repeatedly reactive on EIA and negative on Western blot. Donors with persistently indeterminate Western blots had a band pattern nearly identical to that on the original Western blot. No donor was positive in Western blot, p24 antigen, or PCR testing. No donor had signs or symptoms of HIV-1 infection. CONCLUSION: Long-term follow-up of Western blot-indeterminate blood donors does not reveal evidence of HIV-infection. A mechanism to return these donors to the donor pool should be considered. 相似文献
876.
877.
We present cell cycling and functional evidence that the CD34+CD38- immunophenotype can be used to define a rare and primitive subpopulation of progenitor cells in umbilical cord blood. CD34+CD38- cells comprise 0.05% +/- 0.08% of the mononuclear cells present in cord blood. Cell cycle analysis with the fluorescent DNA stain 7- aminoactinomycin D showed that the percentage of CD34+ cells in cycle directly correlated with increasing CD38 expression. CD34+CD38- cord blood cells were enriched for long-term culture-initiating cells (LTCIC; cells able to generate colony-forming unit-cells [CFU-C] after 35 to 60 days of coculture with bone marrow stroma) relative to CD34+CD38- cells. In an extended LTCIC assay, CD34+CD38- cells were able to generate CFU-C between days 60 and 100, clearly distinguishing them from CD34+CD38+ cells that did not generate CFU-C beyond day 40. When plated as single cells, onset of clonal proliferation was markedly delayed in a subpopulation of CD34+CD38- cells; clones (defined as > 100 cells) appeared after 60 days of culture in 2.9% of CD34+CD38- cells. In contrast, 100% of CD34+CD38+ cells formed clones by day 21. Although the CD34+CD38- immunophenotype defines highly primitive populations in both bone marrow and cord blood, important functional differences exist between the two sources. CD34+CD38- cord blood cells have a higher cloning efficiency, proliferate more rapidly in response to cytokine stimulation, and generate approximately sevenfold more progeny than do their counterparts in bone marrow. 相似文献
878.
There are several aerosolized drugs which have been used in the treatment of neonatal respiratory illnesses, such as bronchodilators,
diuretics, and surfactants. Preclinical in vitro and in vivo studies identified a number of variables that affect aerosol efficiency, including particle size, aerosol flows, nebulizer
choice, and placement. Nevertheless, an optimized aerosol drug delivery system for mechanically ventilated infants still does
not exist. Increasing interest in this form of drug delivery requires more controlled and focused research of drug/device
combinations appropriate for the neonatal population. In the present article, we review the research that has been conducted
thus far and discuss the next steps in developing the optimal aerosol delivery system for use in mechanically ventilated neonates. 相似文献
879.
Lukoye Atwoli Abdullah H Baqui Thomas Benfield Raffaella Bosurgi Fiona Godlee Stephen Hancocks Richard Horton Laurie Laybourn-Langton Carlos Augusto Monteiro Ian Norman Kirsten Patrick Nigel Praities Marcel GM Olde Rikkert Eric J Rubin Peush Sahni Richard Smith Nicholas J Talley Sue Turale Damin Vzquez 《Frontline Gastroenterology》2022,13(4):346
880.